Puregene Biotech Limited
About Puregene Biotech Limited
Data last updated:
Puregene Biotech Limited is a public limited company based in Indore, Madhya Pradesh, India, a subsidiary of Simran Farms Limited. It operates in the poultry farming segment of the agriculture sector. It was incorporated on 11 February 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U01222MP1999PLC013303.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.45 Cr. It was formerly known as Simran Breeders Pvt Ltd. It is led by directors including Gurmeet Singh Bhatia and Satinder Pal Singh Bhatia.
Its last annual general meeting (AGM) was held on 31 July 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 1 – B Vikas Rekha Complex Tower Square, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2026, the company reported a revenue of ₹54.64 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹14.22 Lakh (net margin 26%) and EBITDA of ₹20.29 Lakh (EBITDA margin 37.1%).
As per MCA filings, the company has satisfied charges of ₹2.85 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Puregene Biotech Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address1 – B Vikas Rekha Complex Tower Square, Indore, Madhya Pradesh, India – 452001
- IndustryAgriculture, Poultry Farming
To see the full contact details of Puregene Biotech Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Puregene Biotech Limited
FY 2026 filings availablePuregene Biotech Limited reported revenue of ₹54.64 Lakh (up 1% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue rose 1% in the latest year. EBITDA fell 1% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹54.64 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20.29 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 37.1% | ||||
| Net Profit Margin | 26% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Puregene Biotech Limited, buy the company report.
Board of directors of Puregene Biotech Limited
Puregene Biotech has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gurmeet Singh Bhatia | Director | 11 Feb 1999 | 27 Years 8 Months | Current |
| Satinder Pal Singh Bhatia Also directs: Simran Farms Limited | Director | 19 Sep 2024 | 2 Years 1 Months | Current |
| Kawaljeet Singh Bhatia Also directs: Simran Farms Limited, Simran Hatcheries Private Limited, Simran Fertilizers LLP and 5 more | Director | 01 Apr 2002 | 24 Years 7 Months | Current |
| Harender Singh Bhatia Also directs: Simran Farms Limited, Simran Hatcheries Private Limited, Simran Bio Energy Private Limited and 2 more | Director | 11 Feb 1999 | 27 Years 8 Months | Current |
Peer comparison
Puregene Biotech Limited is compared with the 10 companies closest to it by revenue in the Agriculture industry (Poultry Industry), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| XLNT Poultry Farm Private Limited | ₹60.14 Lakh (FY 2021) | Hyderabad, Telangana, India | ||||
| Abhinav Agriservices Private Limited | ₹59.81 Lakh (FY 2025) | -30.0% | Jamshedpur, Jharkhand, India | |||
| Higrovet Nutritions Private Limited | ₹58.92 Lakh (FY 2025) | -95.0% | Bangalore, Karnataka, India | |||
| Purulia Eggs and Poultry Feeds Private Limited | ₹58.64 Lakh (FY 2025) | -37.0% | Raghunathpur, West Bengal, India | |||
| Hari Landmarks Private Limited | ₹57.89 Lakh (FY 2025) | 266.0% | Dabwali, Haryana, India | |||
| Puregene Biotech Limitedthis company | ₹54.64 Lakh (FY 2026) | ₹14.22 Lakh | 26% | 1.0% | Indore, Madhya Pradesh, India | |
| Zold Udp Foods Private Limited | ₹52.02 Lakh (FY 2025) | -5.0% | Udumalpet, Tamil Nadu, India | |||
| Luminous Exports Private Limited | ₹51.99 Lakh (FY 2019) | 29.0% | Puri, Odisha, India | |||
| Ashok Natural Farms Private Limited | ₹49.97 Lakh (FY 2025) | -87.0% | Namakkal, Tamil Nadu, India | |||
| Shyamkanta Poultry Farm Private Limited | ₹49.95 Lakh (FY 2024) | -23.0% | Firozabad, Uttar Pradesh, India | |||
| Diamond Breeders Private Limited | ₹49.93 Lakh (FY 2024) | 118.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Puregene Biotech Limited, buy the company report.
Auditor
Puregene Biotech Limited is audited by Khandelwal Kakani & Co. for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Khandelwal Kakani & Co. | FY 2026 | 001311C |
Shareholding
The shareholding of Puregene Biotech Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Puregene Biotech Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Mar 2004 | 90209547 | Bank of Baroda | ₹35.86 Lakh | Satisfied | |
| 30 Dec 1999 | 80052399 | Bank of Baroda | ₹12 Lakh | Satisfied | |
| 30 Dec 1999 | 80052400 | Bank of Baroda | ₹1.58 Cr | Satisfied | |
| 30 Dec 1999 | 90201799 | Bank of Baroda | ₹79 Lakh | Satisfied |
To see the full charge records of Puregene Biotech Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Puregene Biotech Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Puregene Biotech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Puregene Biotech Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Puregene Biotech Limited has 4 board changes on record since 1999: 4 appointments. The latest: Satinder Pal Singh Bhatia was appointed as Director on 19 Sep 2024.
4 earlier events are in the company report.
Frequently asked questions
Puregene Biotech is an active public limited company based in Indore, Madhya Pradesh, India. The company works in poultry farming, within the agriculture industry. It was incorporated on 11 February 1999 (27+ years old) and is registered under CIN U01222MP1999PLC013303.
Puregene Biotech has 4 current directors:
- Gurmeet Singh Bhatia - Director
- Satinder Pal Singh Bhatia - Director
- Kawaljeet Singh Bhatia - Director
- Harender Singh Bhatia - Director
The latest financial statements of Puregene Biotech on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 31 July 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Puregene Biotech is U01222MP1999PLC013303. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Puregene Biotech was incorporated on 11 February 1999, making it 27+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Puregene Biotech by revenue are XLNT Poultry Farm Private Limited, Abhinav Agriservices Private Limited, Higrovet Nutritions Private Limited, Purulia Eggs and Poultry Feeds Private Limited, Hari Landmarks Private Limited and 5 more, all in the Agriculture industry (Poultry Industry).
Satinder Pal Singh Bhatia was appointed as Director on 19 Sep 2024. Kawaljeet Singh Bhatia was appointed as Director on 01 Apr 2002. Gurmeet Singh Bhatia was appointed as Director on 11 Feb 1999. Puregene Biotech has 4 board changes on record in total.
The registered office of Puregene Biotech is at 1 – B Vikas Rekha Complex Tower Square, Indore, Madhya Pradesh, India – 452001.
Puregene Biotech operates in the agriculture industry, in the poultry farming segment.
Puregene Biotech has no open charges and satisfied charges of ₹2.85 Cr as per latest MCA filings.
The compliance status of Puregene Biotech is compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
